| Primary |
| Product Used For Unknown Indication |
43.2% |
| Growth Hormone Deficiency |
16.9% |
| Hypopituitarism |
7.0% |
| Body Height Below Normal |
6.6% |
| Dwarfism |
5.3% |
| Small For Dates Baby |
3.7% |
| Constipation |
2.9% |
| Growth Retardation |
2.5% |
| Adrenal Insufficiency |
1.2% |
| Convulsion |
1.2% |
| Failure To Thrive |
1.2% |
| Mineral Supplementation |
1.2% |
| Stomatitis |
1.2% |
| Blood Corticotrophin Abnormal |
0.8% |
| Diabetes Insipidus |
0.8% |
| Hyperlipidaemia |
0.8% |
| Hypertension |
0.8% |
| Hypogonadism |
0.8% |
| Noonan Syndrome |
0.8% |
| Thyroidectomy |
0.8% |
|
| Condition Aggravated |
16.4% |
| Death |
13.1% |
| Headache |
8.2% |
| Epilepsy |
4.9% |
| Fibrous Dysplasia Of Bone |
4.9% |
| Shunt Malfunction |
4.9% |
| Urticaria |
4.9% |
| Acute Lymphocytic Leukaemia |
3.3% |
| Blood Sodium Increased |
3.3% |
| Bone Sarcoma |
3.3% |
| Clostridial Infection |
3.3% |
| Convulsion |
3.3% |
| Cyst |
3.3% |
| Dyspnoea |
3.3% |
| Hospitalisation |
3.3% |
| Impaired Healing |
3.3% |
| Joint Dislocation |
3.3% |
| Neoplasm Recurrence |
3.3% |
| No Adverse Event |
3.3% |
| Osteochondrosis |
3.3% |
|
| Secondary |
| Product Used For Unknown Indication |
39.8% |
| Growth Hormone Deficiency |
16.9% |
| Body Height Below Normal |
7.2% |
| Small For Dates Baby |
3.6% |
| Attention Deficit/hyperactivity Disorder |
2.4% |
| Blood Corticotrophin Abnormal |
2.4% |
| Foetal Growth Restriction |
2.4% |
| Growth Retardation |
2.4% |
| Hyperlipidaemia |
2.4% |
| Hypersensitivity |
2.4% |
| Hypopituitarism |
2.4% |
| Silver-russell Syndrome |
2.4% |
| Thyroidectomy |
2.4% |
| Vitamin B Complex Deficiency |
2.4% |
| Vitamin B12 Deficiency |
2.4% |
| Blood Thyroid Stimulating Hormone Decreased |
1.2% |
| Constipation |
1.2% |
| Focal Nodular Hyperplasia |
1.2% |
| Multiple Allergies |
1.2% |
| Renal Failure Chronic |
1.2% |
|
| Acute Lymphocytic Leukaemia |
8.7% |
| Hypertrophic Cardiomyopathy |
8.7% |
| Urinary Incontinence |
8.7% |
| Blood Glucose Increased |
4.3% |
| Cerebellar Atrophy |
4.3% |
| Clostridial Infection |
4.3% |
| Condition Aggravated |
4.3% |
| Coronary Artery Bypass |
4.3% |
| Craniopharyngioma |
4.3% |
| Csf Shunt Operation |
4.3% |
| Cyst |
4.3% |
| Dehydration |
4.3% |
| Dyspnoea |
4.3% |
| Glioblastoma Multiforme |
4.3% |
| Iliac Artery Embolism |
4.3% |
| Juvenile Melanoma Benign |
4.3% |
| Lobar Pneumonia |
4.3% |
| Neoplasm Progression |
4.3% |
| Nephrolithiasis |
4.3% |
| Papilloedema |
4.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
87.5% |
| Crohn's Disease |
12.5% |
|
| Injection Site Pain |
100.0% |
|
